USPTO Office Action, and Myriad Genetics' Subsequent Response

Date
1997
Authors
United States Patent and Trade Office
Myriad Genetics, Inc.
Repository Usage Stats
174
views
82
downloads
Description
The USPTO requested that Myriad restrict its application to one invention, and suggested ways to group claims in distinct inventions; Myriad responded with alternate combinations of claims into fewer new distinct inventions.
Type
Other
Subject
Genetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health
Permalink
https://hdl.handle.net/10161/7674
Citation
United States Patent and Trade Office; & Myriad Genetics, Inc. (1997). USPTO Office Action, and Myriad Genetics' Subsequent Response. Retrieved from https://hdl.handle.net/10161/7674.
Collections
More Info
Show full item record